The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $24.76

Today's change-0.22 -0.88%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.
 

Sabra Health Care REIT Inc

Nasdaq: SBRA
Last

(U.S.) $24.76

Today's change-0.22 -0.88%
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Sabra Health Care REIT Inc down (U.S.)$0.22

Sabra Health Care REIT Inc closed lower Friday, dropping (U.S.)$0.22 or 0.88% to (U.S.)$24.76. Over the last five days, shares have lost 5.06% and sit 3.62% above their 52-week low. This security has underperformed the S&P 500 by 12.21% during the last year.

Key company metrics

  • Open(U.S.) $24.89
  • Previous close(U.S.) $24.98
  • High(U.S.) $24.94
  • Low(U.S.) $24.49
  • Bid / Ask-- / --
  • YTD % change-18.47%
  • Volume254,634
  • Average volume (10-day)340,417
  • Average volume (1-month)374,123
  • Average volume (3-month)482,553
  • 52-week range(U.S.) $23.90 to (U.S.) $34.44
  • Beta1.07
  • Trailing P/E20.95×
  • P/E 1 year forward19.86×
  • Forward PEG5.03×
  • Indicated annual dividend(U.S.) $1.64
  • Dividend yield6.62%
  • Trailing EPS(U.S.) $1.18
Updated August 28 4:00 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+35.73%

Based on its net profit margin of 35.73%, Sabra Health Care REIT Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.71%Sector:Cyclical Consumer Goods & ServicesIndustry:Hotels, Motels & Cruise Lines
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue57565644
Total other revenue--------
Total revenue57565644
Gross profit--------
Total cost of revenue--------
Total operating expense41363827
Selling / general / administrative13896
Research & development--------
Depreciation / amortization14141410
Interest expense (income), net operating14141411
Unusual expense (income)0000
Other operating expenses, total--------
Operating income15201817
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets2--4--
Other--------
Income before tax17192217
Income after tax17192217
Income tax, total------0
Net income17192217
Total adjustments to net income-3-3-3-3
Net income before extra. items17192217
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items14172015
Inc. avail. to common incl. extra. items14172015
Diluted net income14172015
Dilution adjustment------0
Diluted weighted average shares60605648
Diluted EPS excluding extraordinary itemsvalue per share0.240.280.350.31
Dividends per sharevalue per share0.390.450.390.38
Diluted normalized EPSvalue per share0.210.280.280.31